Repatriation Medical Authority - Notice of Investigation - Immersion Pulmonary Oedema

Overview

The Repatriation Medical Authority, established under the Veterans' Entitlements Act 1986, has announced its intention to investigate the potential for determining Statements of Principles regarding immersion pulmonary oedema. This investigation aims to ascertain the extent to which immersion pulmonary oedema, or death from it, may be categorised as war-caused, defence-caused, a service injury, a service disease, or a service death. The notice invites submissions from various stakeholders, including eligible claimants for pension or compensation, representative organisations, relevant commissions, and experts in relevant fields. The purpose of these submissions is to provide information that may assist in determining whether there is sufficient evidence to warrant the creation of Statements of Principles. Submissions can be made electronically, by email, or by post, and must be received by the Authority no later than 2 December 2016. This initiative is part of the Authority's ongoing effort to ensure that veterans and their families receive appropriate recognition and support for service-related conditions.

Scope and Application

Section 196G of the Veterans' Entitlements Act 1986 (VEA) mandates the Repatriation Medical Authority (RMA) to conduct an investigation into whether Statements of Principles may be determined for immersion pulmonary oedema, with the goal of understanding how this condition may be suffered or contracted, and whether it is war-caused, defence-caused, a service injury, a service disease, or a service death. The investigation applies to a range of stakeholders including individuals eligible to claim pensions or compensation under the VEA or the Military Rehabilitation and Compensation Act 2004, organisations representing veterans and other specified groups, the Repatriation Commission or the Military Rehabilitation and Compensation Commission, and experts in relevant fields. The RMA invites these entities to submit written statements by 2 December 2016, which can be lodged electronically via the RMA website, emailed to a specified address, or posted to a designated postal address. This notice underscores the RMA’s commitment to a comprehensive review of available information, ensuring that the investigation is informed by a wide range of perspectives and expertise.

Key Provisions

The key operative sections of this legislation pertain to the investigation of immersion pulmonary oedema under section 196G of the Veterans' Entitlements Act 1986 (VEA) (section 196G). The Repatriation Medical Authority (the Authority) is mandated to determine if Statements of Principles can be established regarding immersion pulmonary oedema, and whether it qualifies as a war-caused, defence-caused, service injury, service disease, or service death (section 196B(4)). The Authority is inviting written submissions from eligible parties by 2 December 2016, including those who can claim pension or compensation, relevant organisations, and experts (section 196G). Submissions can be made electronically, by email, or by post, with guidelines available on the RMA website (section 196G). The obligations imposed by this Act on the parties include the requirement for eligible individuals and organisations to submit their written submissions to the Authority by the specified deadline (section 196G). The Authority must consider these submissions as part of its investigation into immersion pulmonary oedema. The Act also obliges the Authority to investigate whether immersion pulmonary oedema is war-caused, defence-caused, a service injury, a service disease, or a service death, and to determine if Statements of Principles can be established (section 196B(4)). The Authority must hold its first meeting for this investigation on 6 December 2016 (section 196G). There are no explicit offences, penalties, or civil/criminal consequences mentioned in the text for failing to comply with the Act's requirements. However, the seriousness of the investigation into potential service-related conditions suggests that non-compliance with the submission deadlines or other obligations could result in significant repercussions for the involved parties. It is important for all eligible individuals and organisations to ensure timely and accurate submissions to facilitate the Authority's investigation. The text does not specify maximum penalties for non-compliance with the Act's provisions. However, given the importance of the investigation into immersion pulmonary oedema and the potential impact on affected veterans and their dependants, it is likely that the Authority would take seriously any failure to adhere to the submission requirements or other obligations outlined in the Act. The consequences of such non-compliance could include the inability to establish Statements of Principles for immersion pulmonary oedema and, consequently, the denial of benefits and entitlements to affected individuals. In summary, the legislation under section 196G of the VEA requires the Authority to investigate immersion pulmonary oedema and determine if it qualifies as a war-caused, defence-caused, service injury, service disease, or service death. Eligible parties must submit their written submissions by 2 December 2016, and the Authority will consider these submissions in its investigation. The text does not explicitly state penalties for non-compliance, but the importance of the investigation suggests that failure to comply with the Act's requirements could have significant consequences for affected individuals and organisations.